Using Mounjaro to Lose a Stone: a Realistic Picture

Step 1: the clinical starting point before the weight starts moving

Before Mounjaro does anything, a prescriber has to say yes. That is not a formality, it is the point at which someone checks that your BMI, health history, and current medicines all make tirzepatide appropriate. The licensed threshold is BMI 30 or above, or BMI 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for certain ethnic backgrounds under UK guidance.

Once approved, treatment begins at the 2.5 mg starter dose. Its job is to give your system time to adjust, not to produce dramatic weight loss in week one. Most people notice their appetite beginning to shift within the first fortnight, though the scales may not move much yet. Patience at this stage pays off later, pushing through the initial weeks at the lower dose sets up better tolerance when the dose increases.

If you want a thorough look at how the titration process works in practice, our guide to losing weight on Mounjaro covers the lifestyle factors that matter most alongside treatment.

Step 2: building through the dose schedule, where a stone typically starts to materialise

Mounjaro is available in six UK strengths: 2.5, 5, 7.5, 10, 12.5, and 15 mg. Your prescriber titrates upward, typically in four-week steps, based on how you are tolerating the current dose. For most people, the period between 5 mg and 10 mg is where a stone of loss starts to become visible on the scales.

The SURMOUNT-1 trial (which randomised 2,539 adults with obesity over 72 weeks, published in the New England Journal of Medicine) found that participants on the highest dose lost an average of around 20–21% of their body weight. A stone is roughly 6–8% of body weight for someone in the 80–100 kg range, which means many people reach that milestone before hitting the maintenance dose, as you can read in one patient's account of losing 3 stone on Mounjaro. Heavier starting weights tend to produce faster absolute losses in the early months, even if the percentage is similar.

Side effects are most noticeable after starting or after a dose increase: nausea, loose stools, reduced appetite, and occasional fatigue are common and usually settle within a week or two. The NHS medicines page for tirzepatide lists what to expect and when to seek advice.

Step 3: the lifestyle layer that determines whether a stone stays lost

Mounjaro reduces appetite, it does not replace the need to eat well or move more. The clinical trials paired tirzepatide with a reduced-calorie diet and increased physical activity, and that combination is what produced the published figures. Removing that context does not make the medicine stop working, but it does put a ceiling on your results.

Protein intake matters more than most people expect on a GLP-1 treatment, because appetite suppression can lead to under-eating overall, which risks losing muscle alongside fat. Staying hydrated, keeping up fibre, and building in some resistance or weight-bearing activity are the details that compound over months. Personal targets should be discussed with your prescriber or a dietitian, not set from a population average.

Some people find it useful to time their first consultation around a natural reset: the start of the month, after a holiday, or when a quieter stretch at work means they can focus on the lifestyle changes that run alongside treatment. There is no universally perfect moment, but consistency from the start matters more than the date you begin. Tips for getting more from Mounjaro covers the habits worth building early.

Step 4: setting expectations, timelines, variation, and what comes next

A stone in a month is possible for some people, particularly those with a higher starting weight, but it is not the norm and should not be the baseline expectation. Whether a stone a month is realistic is a question worth reading carefully before drawing up a timeline.

A more typical pattern is steady progress over three to five months to reach that first stone, with faster loss early (partly water and glycogen) and more consistent fat loss as the dose builds. People who go on to lose more describe a similar arc: losing two stone on Mounjaro follows the same process but takes longer and usually requires reaching a higher maintenance dose.

NICE's appraisal of tirzepatide (TA1026) includes a review point: if less than 5% weight loss is achieved after six months at the highest tolerated dose, continuing is reconsidered. That is a clinical checkpoint, not a deadline, and it is one your prescriber manages with you, not something to navigate alone. The broader context of how tirzepatide works as a treatment is worth understanding before starting.

If you are ready to find out whether Mounjaro is appropriate for you, start your free consultation with our prescribers. A named, GPhC-registered clinician reviews every application the same day.